Second Philly Risperdal Mass Tort Case Heads To Jury
The second Philadelphia jury tasked with assessing the connection between Janssen Pharmaceuticals Inc.'s antipsychotic drug Risperdal and the medical condition gynecomastia began deliberations Thursday in a case brought by a boy...To view the full article, register now.
Already a subscriber? Click here to view full article